header logo image

Novo Nordisk’s sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024

August 7th, 2024 2:39 am

Bagsværd, 7 August 2024 - Financial report for the period 1 January 2024 to 30 June 2024

See the original post here:
Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick